Treatment for patients with postmenopausal osteoporosis who have been placed on HRT and show a decrease in bone mineral density: Effects of concomitant administration of vitamin K2

Journal of Bone and Mineral Metabolism

Volumn 20, Issue 4, 2002, Pages 235-239

  Hidaka, Takao ^a   Hasegawa, Toru ^b   Fujimura, Masaki ^a   Sakai, Masatoshi ^a   Saito, Shigeru ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b Yatsuo General Hospital   (Japan)

Author keywords

HRT; Osteoporosis; Vitamin K2

Indexed keywords

CONJUGATED ESTROGEN; FARNOQUINONE; MEDROXYPROGESTERONE ACETATE; MENATETRENONE; ESTROGEN;

ADULT; ARTICLE; BONE DENSITY; CONTROLLED STUDY; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; DRUG COMBINATION; DRUG EFFECT; ESTROGEN THERAPY; MIDDLE AGED; TREATMENT OUTCOME;

BONE DENSITY; DRUG THERAPY, COMBINATION; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; TREATMENT OUTCOME; VITAMIN K 2;

EID: 0036043865     PISSN: 09148779     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007740200034     Document Type: Article

References (31)

1. Christiansen C, Christensen MS, Transbol I (1981) Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy. Lancet 28:459-461
2. Armamento-Villareal R, Civitelli R (1995) Estrogen action on the bone mass of postmenopausal women is dependent on body mass and initial bone mineral density. J Clin Endocrinol Metab 80:776-782
3. Lindsay R, Hart DM, Aitken JM, MacDonald EB, Anderson JB, Clarke AC (1976) Long-term prevention of postmenopausal osteoporosis by oestrogen. Lancet 15:1038-1041
4. Nielsen SP, Barenholdt O, Hermansen F, Munk-Jensen N (1994) Magnitude and pattern of skeletal response to long term continuous and cyclic sequential oestrogen/progestin treatment. Br J Obstet Gynaecol 101:319-324
5. The Writing Group for the PEPI Trial (1996) Effects of hormone therapy on bone mineral density. JAMA 276:1389-1396
6. Komulainen M, Kroger H, Tuppurainen MT, Heikkinen AM, Alhava E, Honkanen R, Jurvelin J, Saarikoski S (1999) Prevention of femoral and lumbar bone loss with hormone replacement therapy and vitamin D3 in early postmenopausal women: a population-based 5-year randomized trial. J Clin Endocrinol Metab 84:546-552
7. Chen M, Chow SN (2001) Additive effect of alfacalcidol on bone mineral density of the lumbar spine in Taiwanese postmenopausal women treated with hormone replacement therapy and calcium supplementation: a randomized 2-year study. Clin Endocrinol 55:253-258
8. Recker RR, Davies KM, Dowd RM, Heaney RP (1999) The effect of low-dose continuous estrogen and progesterone therapy with calcium and vitamin D on bone in elderly women. A randomized, controlled trial. Ann Intern Med 130:897-904
9. Komulainen MH, Kroger H, Tuppurainen MT, Heikkinen AM, Alhava E, Honkanen R, Saarikoski S (1998) HRT and Vit D in prevention of non-vertebral fractures in postmenopausal women; a 5-year randomized trial. Maturitas 31:45-54
10. Heikkinen A, Parviainen MT, Tuppurainen MT, Niskanen L, Komulainen MH, Saarikoski S (1998) Effects of postmenopausal hormone replacement therapy with and without vitamin D3 on circulating levels of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D. Calcif Tissue Int 62:26-30
11. Cortet B, Bera-Louville A, Gauthier P, Gauthier A, Marchandise X, Delcambre B (2001) Comparative efficacy and safety study of etidronate and alendronate in postmenopausal osteoporosis: effect of adding hormone replacement therapy. Joint Bone Spine 68:410-415
12. Harris ST, Eriksen EF, Davidson M, Ettinger MP, Moffett AH Jr, Baylink DJ, Crusan CE, Chines AA (2001) Effect of combined risedronate and hormone replacement therapies on bone mineral density in postmenopausal women. J Clin Endocrinol Metab 86:1890-1897
13. Wimalawansa SJ (1998) A 4-year randomized controlled trial of hormone replacement and bisphosphonate, alone or in combination, in women with postmenopausal osteoporosis. Am J Med 104:219-226
14. Wimalawansa SJ (1995) Combined therapy with estrogen and etidronate has an additive effect on bone mineral density in the hip and vertebrae: 4-year randomized study. Am J Med 99:36-42
15. Da Silva Libre R, Murillo K, Chu D (1998) Comparative study in postmenopausal women with osteoporosis (sodium alendronate, calcium and HRT vs sodium alendronate and calcium). Rev Med Panama 23:34-38
16. Dawson-Hughes B (1998) Calcium enhances HRT for bones. Health News 4:2-3
17. Aloia JF, Vaswani A, Yeh JK, Russo L (1996) Differential effects of dietary calcium augmentation and hormone replacement therapy on bone turnover and serum levels of calcitrophic hormones. Osteoporos Int 6:55-62
18. Lindsay R, Tohme JF (1990) Estrogen treatment of patients with established postmenopausal osteoporosis. Obstet Gynecol 76:290-295
19. Albright F, Smith PH, Richardson AM (1941) Postmenopausal osteoporosis - its clinical feature. JAMA 116:2465-2474
20. Kanai T, Takagi T, Masuhiro K, Nakamura M, Iwata M, Saji F (1997) Serum vitamin K level and bone mineral density in post-menopausal women. Int J Gynaecol Obstet 56:25-30
21. 2 are decreased in elderly women with hip fracture. J Bone Miner Res 8:1241-1245
22. Matsunaga S, Ito H, Sakou T (1999) The effect of vitamin K and D supplementation on ovariectomy-induced bone loss. Calcif Tissue Int 65:285-289
23. Douglas AS, Robins SP, Hutchison JD. Porter RW, Stewart A, Reid DM (1995) Carboxylation of osteocalcin in post-menopausal osteoporotic women following vitamin K and D supplementation. Bone 17:15-20
24. Knapen MH, Hamulyak K, Vermeer C (1989) The effect of vitamin K supplementation on circulating osteocalcin (bone Gla protein) and urinary calcium excretion. Ann Intern Med 111: 1001-1005
25. Tsuji H, Honke K, Hasui M (1998) Effects of a vitamin K2 preparation in severely handicapped patients complicated by osteopenia. Brain Dev 30:477-482
26. Hassager C, Jensen SB, Christiansen C (1994) Non-responders to hormone replacement therapy for the prevention of postmenopausal bone loss: do they exist? Osteoporos Int 4:36-41
27. Shearer MJ (1997) The roles of vitamins D and K in bone health and osteoporosis prevention. Proc Nutr Soc 56:915-937
28. Sato Y, Honda Y, Kuno H, Oizumi K (1998) Menatetrenone ameliorates osteopenia in disuse-affected limbs of vitamin D- and K-deficient stroke patients. Bone 23:291-296
29. 3 and estrogen-progestin therapy. Maturitas 31:161-164
30. Eriksen EF, Colvard DS, Berg NJ, Graham MI, Mann KG, Spelsberg TC, Riggs BL (1988) Evidence of estrogen receptors in normal human osteoblast-like cells. Science 241:84-86
31. Miyaura C, Kusano K, Masuzawa T, Chaki O, Onoe Y, Aoyagi M, Sasaki T, Tamura T, Koishihara Y, Ohsugi Y (1995) Endogenous bone-resorbing factors in estrogen deficiency: cooperative effects of IL-1 and IL-6. J Bone Miner Res 10:1365-1373